The global female infertility diagnosis and treatment market is projected to grow at a CAGR of 4%, during the forecast period. The market growth is attributed to the advancement in treatment options for the proper treatment of female infertility. One such treatment for fertility is assisted reproductive technology (ART) in which the egg and sperm are processed for the treatment of female infertility. The several types of ART treatment include ovulation induction (OI), artificial insemination (AI), donor conception, in-vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and surrogacy. Among these ART, IVF is the most popular treatment technique for treating infertility. 
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/female-infertility-market-size
In IVF treatment, the high-tech device, embryo scope is used to monitor the development of the fertilized eggs without removing them from the protected incubator. As it does not involve the removal of fertilized eggs from the incubator, it minimizes the risk of anything going wrong, and provides doctors and patients with insight into how the embryo is developing. The use of embryo scope improves the chance of patients carrying a pregnancy to term, therefore the use of embryo scope for the infertility treatment is anticipated to drive the growth of the global female infertility diagnosis and treatment market.
A Full Report of Global Female Infertility Diagnosis And Treatment Market is Available at: https://www.omrglobal.com/industry-reports/female-infertility-market-size
Intracytoplasmic sperm injection is also an ART that involves direct injection of a single sperm to the oocyte by the use of a high-resolution microscope equipped with micromanipulators. This highly complex technique is used when the sperm count is too low or when the sperm is unable to penetrate the egg. This procedure involves the extraction of the egg, after the controlled ovarian stimulation, for the subsequent injection of one sperm by egg. After these one or two embryos are transferred to the uterus of the mother through the vagina. The intracytoplasmic sperm injection procedure is painless and requires no anesthesia. Such advancement in the infertility treatment is fueling the growth of the female infertility diagnosis and treatment market. 
Current market trends covered in the market report
North America held a major market share in terms of revenue generation.
Companies are shifting their focus on R&D to develop highly efficient and cost-effective testing methods.
Partnerships and collaborations – key drivers of competition in this market.
Technological advancements in treatment methods to encourage demand for female infertility diagnosis and treatment.
The rapid increase in the number of IVF testing.
Global Female Infertility Diagnosis and Treatment Market Segmentation
By Diagnosis
Ovulation Testing 
Hysterosalpingography
Hysteroscopy
Imaging Testing
Ovarian Reserve Testing
Hormonal Level Testing
Genetic Testing
Others
By Treatment
Drugs and Medicine
Surgery
Intrauterine Insemination (IUI)
Assisted Reproductive Technology (ART)
Others
Global Female Infertility Diagnosis and Treatment Market – Segment by Region 
North America           
US
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific    
China
Japan
India
Rest of Asia-Pacific
Rest of the World
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/female-infertility-market-size
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404